Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regeneron Pharmaceuticals Total Liabilities and Share Holders Equity 2010-2025 | REGN

Regeneron Pharmaceuticals total liabilities and share holders equity from 2010 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Regeneron Pharmaceuticals total liabilities and share holders equity for the quarter ending March 31, 2025 was $37.545B, a 9.24% increase year-over-year.
  • Regeneron Pharmaceuticals total liabilities and share holders equity for 2024 was $37.759B, a 14.15% increase from 2023.
  • Regeneron Pharmaceuticals total liabilities and share holders equity for 2023 was $33.08B, a 13.23% increase from 2022.
  • Regeneron Pharmaceuticals total liabilities and share holders equity for 2022 was $29.215B, a 14.86% increase from 2021.
  
Regeneron Pharmaceuticals Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $37,759
2023 $33,080
2022 $29,215
2021 $25,435
2020 $17,163
2019 $14,805
2018 $11,735
2017 $8,764
2016 $6,973
2015 $5,609
2014 $3,838
2013 $2,951
2012 $2,080
2011 $1,324
2010 $1,089
2009 $741
Regeneron Pharmaceuticals Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2025-03-31 $37,545
2024-12-31 $37,759
2024-09-30 $37,442
2024-06-30 $36,087
2024-03-31 $34,370
2023-12-31 $33,080
2023-09-30 $32,163
2023-06-30 $30,658
2023-03-31 $30,060
2022-12-31 $29,215
2022-09-30 $27,678
2022-06-30 $27,206
2022-03-31 $26,349
2021-12-31 $25,435
2021-09-30 $23,672
2021-06-30 $21,486
2021-03-31 $17,772
2020-12-31 $17,163
2020-09-30 $16,084
2020-06-30 $14,429
2020-03-31 $15,758
2019-12-31 $14,805
2019-09-30 $13,939
2019-06-30 $13,174
2019-03-31 $12,855
2018-12-31 $11,735
2018-09-30 $10,806
2018-06-30 $9,952
2018-03-31 $9,373
2017-12-31 $8,764
2017-09-30 $8,701
2017-06-30 $8,106
2017-03-31 $7,817
2016-12-31 $6,973
2016-09-30 $6,828
2016-06-30 $6,205
2016-03-31 $5,904
2015-12-31 $5,609
2015-09-30 $5,183
2015-06-30 $4,527
2015-03-31 $4,199
2014-12-31 $3,838
2014-09-30 $3,739
2014-06-30 $3,456
2014-03-31 $3,260
2013-12-31 $2,951
2013-09-30 $2,640
2013-06-30 $2,378
2013-03-31 $2,276
2012-12-31 $2,080
2012-09-30 $1,661
2012-06-30 $1,458
2012-03-31 $1,350
2011-12-31 $1,324
2011-09-30 $983
2011-06-30 $1,047
2011-03-31 $1,074
2010-12-31 $1,089
2010-09-30 $942
2010-06-30 $791
2010-03-31 $787
2009-12-31 $741
2009-09-30 $742
2009-06-30 $742
2009-03-31 $681
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $56.250B $14.202B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $217.309B 16.22
Amgen (AMGN) United States $150.079B 13.44
Gilead Sciences (GILD) United States $133.872B 13.90
Vertex Pharmaceuticals (VRTX) United States $113.864B 0.00
Bristol Myers Squibb (BMY) United States $94.937B 6.36
GSK (GSK) United Kingdom $78.925B 9.45
CSL (CSLLY) Australia $76.903B 0.00
Alnylam Pharmaceuticals (ALNY) United States $41.496B 0.00
Argenex SE (ARGX) Netherlands $34.196B 93.34
BioNTech SE (BNTX) Germany $25.515B 0.00
Royalty Pharma (RPRX) United States $19.830B 8.38
Insmed (INSM) United States $19.301B 0.00
Biogen (BIIB) United States $18.597B 8.02
Illumina (ILMN) United States $14.906B 28.28
Genmab (GNMSF) Denmark $13.948B 14.26
Incyte (INCY) United States $13.707B 104.13
Genmab (GMAB) Denmark $13.293B 14.91
Exelixis (EXEL) United States $11.751B 19.95
QIAGEN (QGEN) Netherlands $10.679B 20.78
Moderna (MRNA) United States $10.651B 0.00
Ascendis Pharma (ASND) Denmark $10.573B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
BioMarin Pharmaceutical (BMRN) United States $10.375B 16.85
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $9.984B 0.00
Exact Sciences (EXAS) United States $9.773B 0.00
Bio-Techne Corp (TECH) United States $8.277B 30.88
Blueprint Medicines (BPMC) United States $8.276B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.036B 0.00
Roivant Sciences (ROIV) United Kingdom $7.886B 0.00
Revolution Medicines (RVMD) United States $6.981B 0.00
Repligen (RGEN) United States $6.979B 78.12
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.506B 6.39
Halozyme Therapeutics (HALO) United States $6.473B 12.39
Guardant Health (GH) United States $6.198B 0.00
Legend Biotech (LEGN) United States $6.152B 0.00
TG Therapeutics (TGTX) United States $6.025B 158.12
Nuvalent (NUVL) United States $5.682B 0.00
Telix Pharmaceuticals (TLX) Australia $5.547B 0.00
Axsome Therapeutics (AXSM) United States $5.050B 0.00
Anbio Biotechnology (NNNN) Germany $4.841B 0.00
Alkermes (ALKS) Ireland $4.754B 12.76
Akero Therapeutics (AKRO) United States $4.487B 0.00
ADMA Biologics Inc (ADMA) United States $4.393B 32.86
Vaxcyte (PCVX) United States $4.242B 0.00
Krystal Biotech (KRYS) United States $4.120B 31.75
Cytokinetics (CYTK) United States $4.050B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.033B 0.00
Zai Lab (ZLAB) China $3.993B 0.00
PTC Therapeutics (PTCT) United States $3.927B 6.83
Zealand Pharma (ZLDPF) Denmark $3.910B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.909B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.717B 32.66
Merus (MRUS) Netherlands $3.681B 0.00
Avidity Biosciences (RNA) United States $3.595B 0.00
Arcellx (ACLX) United States $3.569B 0.00
Ascentage Pharma Group - (AAPG) China $3.555B 0.00
SpringWorks Therapeutics (SWTX) United States $3.541B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.509B 0.00
Protagonist Therapeutics (PTGX) United States $3.422B 73.62
Scholar Rock Holding (SRRK) United States $3.369B 0.00
Viking Therapeutics (VKTX) United States $3.164B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.027B 0.00
Metsera (MTSR) United States $3.016B 0.00
Kymera Therapeutics (KYMR) United States $2.977B 0.00
Alvotech (ALVO) Luxembourg $2.840B 16.24
Immunovant (IMVT) United States $2.801B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.674B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.504B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.471B 0.00
ImmunityBio (IBRX) United States $2.463B 0.00
Apellis Pharmaceuticals (APLS) United States $2.313B 0.00
Ligand Pharmaceuticals (LGND) United States $2.232B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.219B 0.00
Twist Bioscience (TWST) United States $2.213B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.195B 0.00
Denali Therapeutics (DNLI) United States $2.105B 0.00
Vericel (VCEL) United States $2.097B 1388.67
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.079B 0.00
Bavarian Nordic (BVNRY) Denmark $2.063B 10.90
Apogee Therapeutics (APGE) United States $2.017B 0.00
CG Oncology (CGON) United States $1.987B 0.00
IDEAYA Biosciences (IDYA) United States $1.952B 0.00
Agios Pharmaceuticals (AGIO) United States $1.949B 0.00
Belite Bio (BLTE) United States $1.907B 0.00
NovoCure (NVCR) Jersey $1.906B 0.00
Disc Medicine (IRON) United States $1.875B 0.00
Certara (CERT) United States $1.853B 34.61
Adaptive Biotechnologies (ADPT) United States $1.847B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.830B 12.16
GRAIL (GRAL) United States $1.776B 0.00
Amicus Therapeutics (FOLD) United States $1.752B 189.67
Beam Therapeutics (BEAM) United States $1.724B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.717B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.694B 0.00
Sarepta Therapeutics (SRPT) United States $1.693B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.608B 0.00
Biohaven (BHVN) United States $1.505B 0.00
Vera Therapeutics (VERA) United States $1.485B 0.00
89BIO (ETNB) United States $1.453B 0.00
ANI Pharmaceuticals (ANIP) United States $1.426B 14.69
Celldex Therapeutics (CLDX) United States $1.405B 0.00
Janux Therapeutics (JANX) United States $1.392B 0.00
Edgewise Therapeutics (EWTX) United States $1.374B 0.00
Mesoblast (MESO) Australia $1.374B 0.00
Travere Therapeutics (TVTX) United States $1.344B 0.00
BGM Group (BGM) China $1.246B 0.00
CureVac (CVAC) Germany $1.211B 5.87
Structure Therapeutics (GPCR) United States $1.209B 0.00
Dynavax Technologies (DVAX) United States $1.194B 71.00
Viridian Therapeutics (VRDN) United States $1.187B 0.00
MannKind (MNKD) United States $1.146B 23.56
AbCellera Biologics (ABCL) Canada $1.116B 0.00
Pacira BioSciences (PCRX) United States $1.098B 10.44
Liquidia Technologies (LQDA) United States $1.097B 0.00
WAVE Life Sciences (WVE) Singapore $1.094B 0.00
Niagen Bioscience (NAGE) United States $1.089B 153.56
Novavax (NVAX) United States $1.053B 2.45
CorMedix Inc (CRMD) United States $1.015B 68.00
Intellia Therapeutics (NTLA) United States $0.995B 0.00
Geron (GERN) United States $0.974B 0.00
Spyre Therapeutics (SYRE) United States $0.966B 0.00
Pharvaris (PHVS) Netherlands $0.936B 0.00
NeoGenomics (NEO) United States $0.921B 0.00
Mineralys Therapeutics (MLYS) United States $0.912B 0.00
Nurix Therapeutics (NRIX) United States $0.903B 0.00
Arcus Biosciences (RCUS) United States $0.900B 0.00
Praxis Precision Medicines (PRAX) United States $0.897B 0.00
Oric Pharmaceuticals (ORIC) United States $0.895B 0.00
MiMedx (MDXG) United States $0.877B 21.21
Zymeworks (ZYME) United States $0.861B 0.00
Oculis Holding AG (OCS) Switzerland $0.851B 0.00
LENZ Therapeutics (LENZ) United States $0.847B 0.00
Cogent Biosciences (COGT) United States $0.835B 0.00
Anavex Life Sciences (AVXL) United States $0.817B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.800B 0.00
ArriVent BioPharma (AVBP) United States $0.780B 0.00
UniQure (QURE) Netherlands $0.779B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Immunome (IMNM) United States $0.765B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Pharming Group (PHAR) Netherlands $0.736B 0.00
Vir Biotechnology (VIR) United States $0.734B 0.00
Replimune (REPL) United States $0.729B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.714B 0.00
Gyre Therapeutics (GYRE) United States $0.692B 184.50
AnaptysBio (ANAB) United States $0.687B 0.00
Immatics (IMTX) Germany $0.679B 0.00
Nuvation Bio (NUVB) United States $0.670B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.667B 0.00
Trevi Therapeutics (TRVI) United States $0.664B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.657B 0.00
Sionna Therapeutics (SION) United States $0.654B 0.00
Sana Biotechnology (SANA) United States $0.647B 0.00
Stoke Therapeutics (STOK) United States $0.646B 14.99
GH Research (GHRS) Ireland $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.615B 0.00
Arbutus Biopharma (ABUS) United States $0.613B 0.00
Urogen Pharma (URGN) United States $0.604B 0.00
Cidara Therapeutics (CDTX) United States $0.603B 0.00
Upstream Bio (UPB) United States $0.589B 0.00
Dianthus Therapeutics (DNTH) United States $0.583B 0.00
Sage Therapeutics (SAGE) United States $0.581B 0.00
Iovance Biotherapeutics (IOVA) United States $0.581B 0.00
Castle Biosciences (CSTL) United States $0.570B 38.72
Arvinas (ARVN) United States $0.569B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.562B 0.00
Maze Therapeutics (MAZE) United States $0.558B 0.00
Keros Therapeutics (KROS) United States $0.549B 0.00
MeiraGTx Holdings (MGTX) United States $0.536B 0.00
Tango Therapeutics (TNGX) United States $0.533B 0.00
Opthea (OPT) Australia $0.525B 0.00
Tyra Biosciences (TYRA) United States $0.522B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.509B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.504B 0.00
Kura Oncology (KURA) United States $0.496B 0.00
Myriad Genetics (MYGN) United States $0.491B 0.00
Septerna (SEPN) United States $0.484B 0.00
Bicara Therapeutics (BCAX) United States $0.480B 0.00
ATyr Pharma (ATYR) United States $0.473B 0.00
Fortrea Holdings (FTRE) United States $0.471B 13.00
Cullinan Therapeutics (CGEM) United States $0.457B 0.00
Abivax SA (ABVX) France $0.456B 0.00
Celcuity (CELC) United States $0.455B 0.00
Kamada (KMDA) Israel $0.454B 27.24
Oxford BioMedica (OXBDF) United Kingdom $0.453B 0.00
Cytek Biosciences (CTKB) United States $0.450B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.445B 0.00
REGENXBIO (RGNX) United States $0.439B 0.00
Rapport Therapeutics (RAPP) United States $0.431B 0.00
PureTech Health (PRTC) United States $0.431B 0.00
Zenas BioPharma (ZBIO) United States $0.425B 0.00
Precigen (PGEN) United States $0.422B 0.00
Fulcrum Therapeutics (FULC) United States $0.398B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.391B 0.00
ITeos Therapeutics (ITOS) United States $0.384B 0.00
MBX Biosciences (MBX) United States $0.377B 0.00
Tectonic Therapeutic (TECX) United States $0.375B 0.00
Eton Pharmaceuticals (ETON) United States $0.374B 0.00
Solid Biosciences (SLDB) United States $0.373B 0.00
Vigil Neuroscience (VIGL) United States $0.371B 0.00
Emergent Biosolutions (EBS) United States $0.371B 0.00
Rezolute (RZLT) United States $0.369B 0.00
Northwest Biotherapeutics (NWBO) United States $0.364B 0.00
Compass Therapeutics (CMPX) United States $0.360B 0.00
Erasca (ERAS) United States $0.357B 0.00
Terns Pharmaceuticals (TERN) United States $0.349B 0.00
Prime Medicine (PRME) United States $0.348B 0.00
Absci (ABSI) United States $0.346B 0.00
Humacyte (HUMA) United States $0.344B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.336B 0.00
Prothena (PRTA) Ireland $0.333B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.333B 0.00
Amarin (AMRN) Ireland $0.329B 0.00
XOMA Royalty (XOMA) United States $0.327B 0.00
Benitec Biopharma (BNTC) United States $0.324B 0.00
Aura Biosciences (AURA) United States $0.316B 0.00
Olema Pharmaceuticals (OLMA) United States $0.312B 0.00
Astria Therapeutics (ATXS) United States $0.307B 0.00
Lifecore Biomedical (LFCR) United States $0.305B 0.00
Inventiva S.A (IVA) France $0.303B 0.00
Atea Pharmaceuticals (AVIR) United States $0.302B 0.00
Abeona Therapeutics (ABEO) United States $0.302B 0.00
Ocugen (OCGN) United States $0.301B 0.00
Aardvark Therapeutics (AARD) United States $0.301B 0.00
Cartesian Therapeutics (RNAC) United States $0.297B 0.00
Gossamer Bio (GOSS) United States $0.295B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.287B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.287B 58.25
Vanda Pharmaceuticals (VNDA) United States $0.284B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.277B 0.00
Alpha Teknova (TKNO) United States $0.273B 0.00
Foghorn Therapeutics (FHTX) United States $0.271B 0.00
Annexon (ANNX) United States $0.269B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.268B 0.00
Sagimet Biosciences (SGMT) United States $0.267B 0.00
Entrada Therapeutics (TRDA) United States $0.266B 8.67
Allogene Therapeutics (ALLO) United States $0.262B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
DBV Technologies S.A (DBVT) France $0.252B 0.00
Candel Therapeutics (CADL) United States $0.252B 0.00
Citius Oncology (CTOR) United States $0.250B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
MaxCyte (MXCT) United States $0.245B 0.00
Prima BioMed (IMMP) Australia $0.238B 0.00
Neurogene (NGNE) United States $0.236B 0.00
Tvardi Therapeutics (TVRD) United States $0.236B 0.00
Verastem (VSTM) United States $0.229B 0.00
Adherex Technologies (FENC) United States $0.229B 0.00
Palvella Therapeutics (PVLA) United States $0.228B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.227B 0.00
BioStem Technologies (BSEM) $0.223B 9.10
Y-mAbs Therapeutics (YMAB) United States $0.217B 0.00
Semper Paratus Acquisition (TVGN) United States $0.217B 0.00
Design Therapeutics (DSGN) United States $0.217B 0.00
Inhibrx Biosciences (INBX) United States $0.214B 0.13
Monopar Therapeutics (MNPR) United States $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
Cardiff Oncology (CRDF) United States $0.210B 0.00
ScPharmaceuticals (SCPH) United States $0.210B 0.00
AC Immune (ACIU) Switzerland $0.210B 0.00
Codexis (CDXS) United States $0.209B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.208B 0.00
SELLAS Life Sciences (SLS) United States $0.203B 0.00
Kodiak Sciences (KOD) United States $0.199B 0.00
CARGO Therapeutics (CRGX) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.192B 0.00
CytomX Therapeutics (CTMX) United States $0.186B 4.81
EnGene Holdings (ENGN) Canada $0.183B 0.00
Alumis (ALMS) United States $0.180B 0.00
Editas Medicine (EDIT) United States $0.177B 0.00
Innate Pharma S.A (IPHA) France $0.176B 0.00
Bright Minds Biosciences (DRUG) United States $0.175B 0.00
Ventyx Biosciences (VTYX) United States $0.174B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.166B 0.00
I-Mab (IMAB) United States $0.165B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.165B 0.00
Voyager Therapeutics (VYGR) United States $0.164B 0.00
Puma Biotechnology (PBYI) United States $0.164B 4.30
DiaMedica Therapeutics (DMAC) United States $0.163B 0.00
Spero Therapeutics (SPRO) United States $0.162B 0.00
Nuvectis Pharma (NVCT) United States $0.161B 0.00
Rapt Therapeutics (RAPT) United States $0.161B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.161B 0.00
BioAge Labs (BIOA) United States $0.156B 0.00
Anika Therapeutics (ANIK) United States $0.155B 0.00
Alector (ALEC) United States $0.150B 0.00
Kyverna Therapeutics (KYTX) United States $0.150B 0.00
Alpha Cognition (ACOG) Canada $0.148B 0.00
Compugen (CGEN) Israel $0.145B 0.00
Instil Bio (TIL) United States $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.145B 0.00
INmune Bio (INMB) United States $0.144B 0.00
Black Diamond Therapeutics (BDTX) United States $0.140B 41.00
Agenus (AGEN) United States $0.135B 0.00
Skye Bioscience (SKYE) United States $0.132B 0.00
Sangamo Therapeutics (SGMO) United States $0.130B 0.00
Neumora Therapeutics (NMRA) United States $0.129B 0.00
Elicio Therapeutics (ELTX) United States $0.126B 0.00
Fate Therapeutics (FATE) United States $0.126B 0.00
Caribou Biosciences (CRBU) United States $0.126B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.123B 0.00
Nkarta (NKTX) United States $0.123B 0.00
Seer (SEER) United States $0.121B 0.00
Greenwich LifeSciences (GLSI) United States $0.119B 0.00
23andMe Holding (MEHCQ) United States $0.118B 0.00
Genelux (GNLX) United States $0.115B 0.00
Immuneering (IMRX) United States $0.115B 0.00
Actuate Therapeutics (ACTU) United States $0.114B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.114B 0.00
Tenaya Therapeutics (TNYA) United States $0.112B 0.00
BioHarvest Sciences (BHST) Canada $0.112B 0.00
Vor Biopharma (VOR) $0.111B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.110B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.109B 0.00
C4 Therapeutics (CCCC) United States $0.108B 0.00
Theratechnologies (THTX) Canada $0.108B 0.00
Contineum Therapeutics (CTNM) United States $0.104B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.104B 0.00
Nautilus Biotechnology (NAUT) United States $0.102B 0.00
BeyondSpring (BYSI) United States $0.102B 0.00
TuHURA Biosciences (HURA) United States $0.100B 0.00
Coya Therapeutics (COYA) United States $0.099B 0.00
HilleVax (HLVX) United States $0.098B 0.00
IO Biotech (IOBT) Denmark $0.098B 0.00
Invivyd (IVVD) United States $0.096B 0.00
Entera Bio (ENTX) Israel $0.091B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.091B 0.00
Adagene (ADAG) China $0.090B 0.00
Whitehawk Therapeutics (WHWK) United States $0.090B 0.00
XBiotech (XBIT) United States $0.088B 0.00
Cabaletta Bio (CABA) United States $0.086B 0.00
Jasper Therapeutics (JSPR) United States $0.085B 0.00
Climb Bio (CLYM) United States $0.085B 0.00
Coherus Oncology (CHRS) United States $0.085B 0.00
TScan Therapeutics (TCRX) United States $0.084B 0.00
Seres Therapeutics (MCRB) United States $0.083B 0.00
Cellectis S.A (CLLS) France $0.083B 0.00
Inovio Pharmaceuticals (INO) United States $0.083B 0.00
OKYO Pharma (OKYO) $0.082B 0.00
EXoZymes (EXOZ) United States $0.081B 0.00
Pliant Therapeutics (PLRX) United States $0.080B 0.00
Zura Bio (ZURA) United States $0.079B 0.00
Elutia (ELUT) United States $0.076B 0.00
Forte Biosciences (FBRX) United States $0.075B 0.00
Biomea Fusion (BMEA) United States $0.075B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.073B 0.00
TELA Bio (TELA) United States $0.073B 0.00
IGM Biosciences (IGMS) United States $0.073B 0.00
Quince Therapeutics (QNCX) United States $0.068B 0.00
Immunic (IMUX) United States $0.068B 0.00
Oncolytics Biotech (ONCY) Canada $0.068B 0.00
Sutro Biopharma (STRO) United States $0.067B 0.00
Akoya Biosciences (AKYA) United States $0.066B 0.00
PDS Biotechnology (PDSB) United States $0.066B 0.00
Ikena Oncology (IKNA) United States $0.065B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.064B 0.00
MediciNova (MNOV) United States $0.064B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Immix Biopharma (IMMX) United States $0.062B 0.00
Alto Neuroscience (ANRO) United States $0.062B 0.00
CervoMed (CRVO) United States $0.062B 0.00
Quantum Biopharma (QNTM) Canada $0.061B 0.00
Opus Genetics (IRD) United States $0.061B 0.00
Repare Therapeutics (RPTX) Canada $0.060B 0.00
Renovaro (RENB) United States $0.060B 0.00
VistaGen Therapeutics (VTGN) United States $0.060B 0.00
Cue Biopharma (CUE) United States $0.059B 0.00
Oncobiologics (OTLK) United States $0.059B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.058B 0.00
Adlai Nortye (ANL) Cayman Islands $0.057B 0.00
ZIVO Bioscience (ZIVO) United States $0.057B 0.00
InflaRx (IFRX) Germany $0.056B 0.00
Genenta Science S.p.A (GNTA) Italy $0.056B 0.00
Adicet Bio (ACET) United States $0.055B 0.00
Senti Biosciences (SNTI) United States $0.055B 0.00
Fortress Biotech (FBIO) United States $0.055B 0.00
Connect Biopharma Holdings (CNTB) United States $0.054B 0.00
Applied Therapeutics (APLT) United States $0.054B 0.00
Adverum Biotechnologies (ADVM) United States $0.052B 0.00
Werewolf Therapeutics (HOWL) United States $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.050B 0.00
RenovoRx (RNXT) United States $0.049B 0.00
Shattuck Labs (STTK) United States $0.048B 0.00
Kalaris Therapeutics (KLRS) United States $0.048B 0.00
Atara Biotherapeutics (ATRA) United States $0.047B 0.00
Precision BioSciences (DTIL) United States $0.046B 0.00
Celularity (CELU) United States $0.046B 0.00
Aligos Therapeutics (ALGS) United States $0.044B 0.00
Annovis Bio (ANVS) United States $0.042B 0.00
Medicus Pharma (MDCX) United States $0.042B 0.00
PepGen (PEPG) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Mersana Therapeutics (MRSN) United States $0.041B 0.00
Pluri (PLUR) Israel $0.040B 0.00
Artiva Biotherapeutics (ARTV) United States $0.038B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.038B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.037B 0.00
ABVC BioPharma (ABVC) United States $0.037B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
Scilex Holding (SCLX) United States $0.037B 0.00
Clene (CLNN) United States $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Exicure (XCUR) United States $0.035B 0.00
Alterity Therapeutics - (ATHE) Australia $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Estrella Immunopharma (ESLA) United States $0.034B 0.00
KALA BIO (KALA) United States $0.034B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.034B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Rani Therapeutics Holdings (RANI) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.028B 0.00
FibroBiologics (FBLG) United States $0.027B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.027B 0.00
Lisata Therapeutics (LSTA) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Ovid Therapeutics (OVID) United States $0.024B 0.00
ALX Oncology Holdings (ALXO) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Generation Bio (GBIO) United States $0.024B 0.00
Dare Bioscience (DARE) United States $0.023B 0.00
Curis (CRIS) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Eyenovia (EYEN) United States $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
BioAtla (BCAB) United States $0.022B 0.00
BRIACELL THERAP (BCTX) Canada $0.021B 0.00
Passage Bio (PASG) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Cadrenal Therapeutics (CVKD) United States $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
CalciMedica (CALC) United States $0.020B 0.00
Longeveron (LGVN) United States $0.019B 0.00
Aytu BioPharma (AYTU) United States $0.019B 0.00
Q32 Bio (QTTB) United States $0.019B 0.00
Gelteq (GELS) Australia $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.017B 0.00
Cingulate (CING) United States $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
Rallybio (RLYB) United States $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Advanced Biomed (ADVB) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Abpro Holdings (ABP) United States $0.014B 0.00
UNITY Biotechnology (UBX) United States $0.014B 0.00
MetaVia (MTVA) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Equillium (EQ) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
IBio (IBIO) United States $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
X4 Pharmaceuticals (XFOR) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
GT Biopharma (GTBP) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Synaptogenix (SNPX) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Portage Biotech (PRTG) $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Moleculin Biotech (MBRX) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00